Skip to main content
Premium Trial:

Request an Annual Quote

Kalorama Information s Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications Study


Kalorama Information has released a study entitled “Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications.”

The study examines market potential for nucleic acid therapeutics in cancer, rheumatoid arthritis, diabetes, hypertension, coronary artery disease, congestive heart failure, psoriasis, lupus erythematosus, psoriatic arthritis, scleroderma, Alzheimer’s disease, Parkinson’s disease, peripheral neuropathy, epilepsy, multiple sclerosis, severe traumatic brain injury, and spinal cord injury. Additionally, the report profiles 30 industry players, said Kalorama.

Additional information about the report can be found at

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.